# FDA Inspection 634715 - Mark L. Brantly, M.D. - December 11, 2009

Source: https://www.keypedia.com/records/fda_inspections/mark-l-brantly-md/61fc5414-e3ba-4dd2-abd8-8054352acb10
Source feed: FDA_Inspections

> FDA Inspection 634715 for Mark L. Brantly, M.D. on December 11, 2009. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 634715
- Company Name: Mark L. Brantly, M.D.
- Inspection Date: 2009-12-11
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1012256 - 2017-04-14](https://www.keypedia.com/records/fda_inspections/mark-l-brantly-md/f513b73e-0d97-438e-aa92-23148817de2d)
- [FDA Inspection 621495 - 2009-09-21](https://www.keypedia.com/records/fda_inspections/mark-l-brantly-md/30116903-a60e-4ba7-97e5-6c77a49856e5)

Company: https://www.keypedia.com/companies/mark-l-brantly-md/e36e3369-a7ca-44c8-9b20-a07af0dbcf6e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d